Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer
about
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma.PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT.Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes
P2860
Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeting ERK enhances the cyt ...... al models of pancreatic cancer
@en
type
label
Targeting ERK enhances the cyt ...... al models of pancreatic cancer
@en
prefLabel
Targeting ERK enhances the cyt ...... al models of pancreatic cancer
@en
P2093
P2860
P356
P1433
P1476
Targeting ERK enhances the cyt ...... al models of pancreatic cancer
@en
P2093
Changwen Ning
Gregory Dyson
Holly Edwards
Jeffrey W Taub
Lijing Zhao
Lisa Polin
Ramzi M Mohammad
Shuang Liu
P2860
P304
44295-44311
P356
10.18632/ONCOTARGET.17869
P407
P577
2017-05-15T00:00:00Z